awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34438331-68BDB507-E619-42DE-BB2A-15F8BE8D1092
Q34438331-68BDB507-E619-42DE-BB2A-15F8BE8D1092
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34438331-68BDB507-E619-42DE-BB2A-15F8BE8D1092
Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficiently.
P2860
Q34438331-68BDB507-E619-42DE-BB2A-15F8BE8D1092
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34438331-68BDB507-E619-42DE-BB2A-15F8BE8D1092
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0dc4d1c4dad937c41eb40e28ae7a1c5a64689906
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.